Evidence map›Paper›PMID 34299115›Full record

ArticleInternational journal of molecular sciences2021

Novel Hybrid Compounds Containing Benzofuroxan and Aminothiazole Scaffolds: Synthesis and Evaluation of Their Anticancer Activity.

Elena Chugunova, Gabriele Micheletti, Dario Telese, Carla Boga, Daut Islamov, Konstantin Usachev, Alexander Burilov, Alena Tulesinova, Alexandra Voloshina, Anna Lyubina and 4 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Bioactive Oxadiazoles 2.0.International journal of molecular sciences · 2022
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Elena ChugunovaFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.ORCID 0000-0002-9371-1877
Gabriele MichelettiDepartment of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum-Universita di Bologna Viale Del Risorgimento, 40136 Bologna, Italy.ORCID 0000-0001-9746-2356
Dario TeleseDepartment of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum-Universita di Bologna Viale Del Risorgimento, 40136 Bologna, Italy.ORCID 0000-0001-9372-0207
Carla BogaDepartment of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum-Universita di Bologna Viale Del Risorgimento, 40136 Bologna, Italy.ORCID 0000-0003-2851-8939
Daut IslamovFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.
Konstantin UsachevKazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of Russian Academy of Sciences, 420111 Kazan, Russia.ORCID 0000-0002-6331-7764
Alexander BurilovFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.
Alena TulesinovaInstitute of Chemical Engineering and Technology, Kazan National Research Technological University, 420015 Kazan, Russia.
Alexandra VoloshinaFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.
Anna LyubinaFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.
Syumbelya AmerhanovaFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.
Tatiana GerasimovaFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.ORCID 0000-0001-8473-5327
Aisylu GilfanovaFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.
Victor SyakaevFRC Kazan Scientific Center, Arbuzov Institute of Organic and Physical Chemistry, Russian Academy of Sciences, 420088 Kazan, Russia.
A.E. Arbuzov Institute of Organic and Physical Chemistry · RUUniversity of Bologna · ITKazan Scientific Center · RUKazan Institute of Biochemistry and Biophysics · RUKazan State Technological University · RU

Funding

Ministry of Education and Science of the Russian Federation 075-15-2019-1881
6 · The paper itself

Abstract

A series of novel hybrid compounds containing benzofuroxan and 2-aminothiazole moieties are synthesized via aromatic nucleophilic substitution reaction. Possible reaction pathways have been considered quantum-chemically, which allowed us to suggest the most probable products. The quantum chemical results have been proved by X-ray data on one compound belonging to the synthesized series. It was shown that the introduction of substituents to both the thiazole and amine moieties of the compounds under study strongly influences their UV/Vis spectra. Initial substances and obtained hybrid compounds have been tested in vitro as anticancer agents. Target compounds showed selectivity towards M-HeLa tumor cell lines and were found to be more active than starting benzofuroxan and aminothiazoles. Furthermore, they are considerably less toxic to normal liver cells compared to Tamoxifen. The mechanism of action of the studied compounds can be associated with the induction of apoptosis, which proceeds along the mitochondrial pathway. Thus, new hybrids of benzofuroxan are promising candidates for further development as anticancer agents.

Indexed as

Antineoplastic AgentsApoptosisBenzoxazolesCell ProliferationDrug Screening Assays, AntitumorFemaleHeLa CellsHumansMolecular StructureOxadiazolesStructure-Activity RelationshipThiazolesUterine Cervical Neoplasms2-aminothiazoleAntineoplastic AgentsbenzofuroxanBenzoxazolesOxadiazolesThiazolesaminothiazoleanticancer activityapoptosisbenzofuroxanquantum chemicalcal culations

Identifiers

PMID34299115
PMCPMC8305974
OpenAlexW3179661602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.